| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mélina Bégou, Philippe Brun, Jean-Baptiste Bertrand, Didier Job, Annie Schweitzer, Thierry D'Amato, Mohamed Saoud, Annie Andrieux, Marie-Françoise Suaud-Chagn. Post-pubertal emergence of alterations in locomotor activity in stop null mice. Synapse (New York, N.Y.). vol 61. issue 9. 2007-11-29. PMID:17559095. |
we suggest that the pattern of locomotor disturbances observed in this study is related to altered dopaminergic reactivity in juvenile mice without major disturbance in glutamatergic transmission, whereas both neurotransmitter systems are impaired in adult mice. |
2007-11-29 |
2023-08-12 |
mouse |
| M Martinez de Lagran, A Bortolozzi, O Millan, J D Gispert, J R Gonzalez, M L Arbones, F Artigas, M Diersse. Dopaminergic deficiency in mice with reduced levels of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A, Dyrk1A(+/-). Genes, brain, and behavior. vol 6. issue 6. 2007-11-06. PMID:17137466. |
dopamine (da) is a key neurotransmitter in motor behavior and genetic deletion of certain genes directly related to the dopaminergic system has a strong impact on motor activity. |
2007-11-06 |
2023-08-12 |
mouse |
| Christina H L Teh, Chin Chieh Loh, Kevin K Y Lam, Jia Min Loo, Tie Yan, Tit Meng Li. Neuronal PAS domain protein 1 regulates tyrosine hydroxylase level in dopaminergic neurons. Journal of neuroscience research. vol 85. issue 8. 2007-11-05. PMID:17457889. |
dopamine is the main neurotransmitter present in dopaminergic neurons of the ventral midbrain, where dysfunction of these neurons can lead to parkinson's disease and schizophrenia. |
2007-11-05 |
2023-08-12 |
mouse |
| Peter V Rabins, David B Arciniega. Pathophysiology of involuntary emotional expression disorder. CNS spectrums. vol 12. issue 4 Suppl 5. 2007-10-04. PMID:17426671. |
this network includes specific cerebral, cerebellar, and brainstem areas and their multiple projections/pathways, with activity modulated through serotonergic, dopaminergic, glutamatergic, and possibly sigma receptor neurotransmitter systems. |
2007-10-04 |
2023-08-12 |
human |
| Alice Guyon, Jean-Louis Naho. Multiple actions of the chemokine stromal cell-derived factor-1alpha on neuronal activity. Journal of molecular endocrinology. vol 38. issue 3. 2007-09-18. PMID:17339399. |
in various neuronal populations (ca1 neurons of the hippocampus, granular and purkinje cells of the cerebellum, melanin-concentrating hormone neurons of the lateral hypothalamus, vasopressinergic neurons of the supraoptic and the paraventricular nucleus of the hypothalamus, and dopaminergic neurons of the substantia nigra), sdf-1alpha can modulate the activity of neurons by multiple regulatory pathways including and often combining: (i) modulation of voltage-dependent channels (sodium, potassium, and calcium), (ii) activation of the g-protein-activated inward rectifier potassium current, and (iii) increase in neurotransmitter release (gamma-amino butyric acid (gaba), glutamate, and dopamine), often through ca-dependent mechanisms. |
2007-09-18 |
2023-08-12 |
Not clear |
| Camila Guindalini, David Collier, Ronaldo Laranjeira, Tom B Barrett, John Kelsoe, Adauto Castelo, Homero Vallada, Gerome Bree. Association analysis of GRK3 gene promoter variants in cocaine abuse. Psychiatric genetics. vol 17. issue 4. 2007-09-17. PMID:17621168. |
the g protein-coupled receptor kinase 3 gene (grk3) is a candidate gene for cocaine addiction because it is involved in the regulation of several neurotransmitter receptors, including the response to dopaminergic agonists such as methamphetamine and cocaine. |
2007-09-17 |
2023-08-12 |
Not clear |
| Thomas I F H Cremers, Kieran Rea, Fokko J Bosker, Håkan V Wikström, Sandra Hogg, Arne Mørk, Ben H C Westerin. Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 32. issue 7. 2007-08-31. PMID:17203017. |
to investigate which neurotransmitter systems were involved in the interaction, systemic citalopram was challenged with several glutamatergic, gaba-ergic, noradrenergic, and dopaminergic compounds to determine their effects on serotonin release in ventral hippocampus. |
2007-08-31 |
2023-08-12 |
Not clear |
| I Martínez-Gras, J Hoecnika, E Pérez-Hernández, R Rodríguez-Jiménez, G Ponce, Ma Jiménez-Arriero, J Ramos-Atance, T Palomo, G Rubi. [Endocannabinoid system and CNR1 gene polymorphisms in schizophrenia and addictive disorders]. Actas espanolas de psiquiatria. vol 35. issue 2. 2007-08-10. PMID:17401783. |
on the other hand this system may be involved in several brain functions through neuromodulation dopaminergic and other neurotransmitter system involved in schizophrenic and substance abuse disorders. |
2007-08-10 |
2023-08-12 |
Not clear |
| Janice H Silva, Renato S Gomez, Paulo H C Diniz, Marcus V Gomez, Cristina Guatimosi. The effect of sevoflurane on the release of [3H]dopamine from rat brain cortical slices. Brain research bulletin. vol 72. issue 4-6. 2007-07-24. PMID:17452291. |
dopamine is a neurotransmitter that exerts major control on important brain functions and some lines of studies suggest that dopaminergic neurotransmission may be a potential target for volatile anesthetics. |
2007-07-24 |
2023-08-12 |
rat |
| Dan Rujescu, Andreas Thalmeier, Hans-Jürgen Möller, Thomas Bronisch, Ina Gieglin. Molecular genetic findings in suicidal behavior: what is beyond the serotonergic system? Archives of suicide research : official journal of the International Academy for Suicide Research. vol 11. issue 1. 2007-05-02. PMID:17178640. |
furthermore, genes of the dopaminergic and noradrenergic neurotransmitter systems have also been the subjects of investigations in this context. |
2007-05-02 |
2023-08-12 |
human |
| Mona Boules, Amanda Shaw, Paul Fredrickson, Elliott Richelso. Neurotensin agonists: potential in the treatment of schizophrenia. CNS drugs. vol 21. issue 1. 2007-05-01. PMID:17190526. |
it is closely associated with, and is thought to modulate, dopaminergic and other neurotransmitter systems involved in the pathophysiology of various neuropsychiatric diseases, including schizophrenia. |
2007-05-01 |
2023-08-12 |
Not clear |
| Anne-Kathrin Ettl, Jochen Holzschuh, Wolfgang Drieve. The zebrafish mutation m865 affects formation of dopaminergic neurons and neuronal survival, and maps to a genetic interval containing the sepiapterin reductase locus. Anatomy and embryology. vol 211 Suppl 1. 2007-04-05. PMID:17024299. |
the effects of the mutation appear not to be restricted to dopaminergic neurons, as development of other neurotransmitter systems (serotonergic and cholinergic) is impaired as well. |
2007-04-05 |
2023-08-12 |
zebrafish |
| Daniel Kondziella, Eiliv Brenner, Elvar M Eyjolfsson, Ursula Sonnewal. How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia? Neurochemistry international. vol 50. issue 2. 2007-03-30. PMID:17084946. |
instead, a more integrative approach combines different neurotransmitter systems, in which glutamatergic, gabaergic and dopaminergic pathways interact. |
2007-03-30 |
2023-08-12 |
human |
| Xiaohui Xu, Keeley Brookes, Chih-Ken Chen, Yu-Shu Huang, Yu-Yu Wu, Philip Asherso. Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. BMC psychiatry. vol 7. 2007-03-19. PMID:17328795. |
molecular genetic and pharmacological studies suggest the involvement of the dopaminergic, serotonergic and noradrenergic neurotransmitter systems in the pathogenesis of adhd. |
2007-03-19 |
2023-08-12 |
Not clear |
| Ujendra Kumar, Shutish C Pate. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain. Brain research. vol 1131. issue 1. 2007-03-09. PMID:17182012. |
another key neurotransmitter system involved with emotion and cognition is the dopaminergic system. |
2007-03-09 |
2023-08-12 |
rabbit |
| Marije van Beilen, Klaus L Leender. Putamen FDOPA uptake and its relationship tot cognitive functioning in PD. Journal of the neurological sciences. vol 248. issue 1-2. 2007-01-23. PMID:16782131. |
in pd, multiple neurotransmitter systems are involved in cognitive functioning, including the dopaminergic system. |
2007-01-23 |
2023-08-12 |
Not clear |
| Richard S Jope, Myoung-Sun Ro. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Current drug targets. vol 7. issue 11. 2007-01-04. PMID:17100582. |
several intracellular signaling cascades converge on gsk3 to modulate its activity, and several neurotransmitter systems also regulate gsk3, including serotonergic, dopaminergic, cholinergic, and glutamatergic systems. |
2007-01-04 |
2023-08-12 |
Not clear |
| Ales Stuchlik, Karel Vale. Effect of dopamine D1 receptor antagonist SCH23390 and D1 agonist A77636 on active allothetic place avoidance, a spatial cognition task. Behavioural brain research. vol 172. issue 2. 2006-12-28. PMID:16781786. |
these findings support the notion that brain dopaminergic d1 neurotransmitter system modulates neural processes underlying spatial cognition. |
2006-12-28 |
2023-08-12 |
rat |
| Leonid Yavich, Pekka Jäkälä, Heikki Tanil. Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice. Journal of neurochemistry. vol 99. issue 3. 2006-12-20. PMID:16824047. |
the effects are essentially the same as previously reported for dopaminergic terminals in the striatum, indicating that the important role of alpha-synuclein in neurotransmitter mobilization is not limited to dopaminergic terminals. |
2006-12-20 |
2023-08-12 |
mouse |
| Robert B Raffa, Gregory W Stagliano, Ronald J Tallarid. Subadditive withdrawal from cocaine/kappa-opioid agonist combinations in Planaria. Brain research. vol 1114. issue 1. 2006-11-28. PMID:16914122. |
planaria are particularly valuable for these studies because of their permeable exteriors and their relevant neurotransmitter systems (e.g., dopaminergic, opioid, and serotonergic). |
2006-11-28 |
2023-08-12 |
Not clear |